Penumbra (PEN) Change in Account Payables (2014 - 2026)

Penumbra's (PEN) quarterly Change in Account Payables came in at $9.0 million in Q1 2026, up 3672.11% year-on-year from $237691.8 in Q1 2025, and up 97.58% on a QoQ basis from $4.5 million in Q4 2025.

Penumbra (PEN) Change in Account Payables (2014 - 2026) Analysis & Trends

Penumbra (PEN) has 13 years of Change in Account Payables data on file, last reported at $9.0 million in Q1 2026.

  • On a quarterly basis, Change in Account Payables rose 3672.11% year-over-year to $9.0 million in Q1 2026; TTM through Mar 2026 was $12.3 million, a 1053.73% increase from a year earlier, with the FY2025 full-year figure at $3.1 million, down 26.49% from the prior year.
  • Change in Account Payables for Q1 2026 stood at $9.0 million, up from $4.5 million in the prior quarter.
  • Over the last five years, Change in Account Payables for PEN reached as high as $9.0 million in Q1 2026 and fell as low as -$3.2 million in Q2 2025.
  • Historically, Change in Account Payables has averaged $1.8 million across 5 years, with a median of $1.4 million in 2022.
  • Across the five-year window, Change in Account Payables tumbled 1248.06% in 2025 and jumped 3672.11% in 2026, its largest moves.
  • Year by year, Change in Account Payables stood at $295000.0 in 2022, then slumped by 424.41% to -$957000.0 in 2023, then slumped by 94.67% to -$1.9 million in 2024, then jumped by 343.59% to $4.5 million in 2025, then surged by 97.58% to $9.0 million in 2026.
  • Per Business Quant data, the three most recent Change in Account Payables figures were $9.0 million in Q1 2026, $4.5 million in Q4 2025, and $2.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -198.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 221.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Penumbra 12.48 Bn 11.87 Bn 253.41 Mn 8.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.97 Mn
Mar 31, 2026 8.97 Mn
Dec 31, 2025 4.54 Mn
Dec 31, 2025 4.54 Mn
Sep 30, 2025 2.03 Mn
Sep 30, 2025 2.03 Mn
Jun 30, 2025 -3.25 Mn
Jun 30, 2025 -3.25 Mn
Mar 31, 2025 -251,000.00
Mar 31, 2025 -251,000.00
Dec 31, 2024 -1.86 Mn
Dec 31, 2024 -1.86 Mn
Sep 30, 2024 543,000.00
Sep 30, 2024 543,000.00
Jun 30, 2024 283,000.00
Jun 30, 2024 283,000.00
Mar 31, 2024 5.21 Mn
Mar 31, 2024 5.21 Mn
Dec 31, 2023 -957,000.00
Dec 31, 2023 -957,000.00